Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New implant aims to strengthen shoulder tendon repair after replacement

NCT ID NCT05735119

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a special implant (Tapestry) that helps repair a key shoulder tendon (subscapularis) during shoulder replacement surgery. About 100 adults with shoulder arthritis or injury will be followed for 2 years to see if the tendon heals better with the implant. The goal is to improve shoulder function and long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2022

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults undergoing shoulder arthroplasty, who meet the study eligibility criteria.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adult, 21 years and older. 2. Patient requires shoulder arthroplasty (anatomic or reverse) with subscapularis repair due to osteoarthritis, rotator cuff injury, rheumatoid arthritis and/or other inflammatory disorder, osteonecrosis, and/or post-traumatic injury (e.g., humerus fractures). 3. Patients healthy enough to undergo primary anatomic or reverse shoulder arthroplasty, in the opinion of the investigator; 4. Patients receiving shoulder arthroplasty with anticipated subscapularis tenotomy (ST) or subscapularis peel (SP). 5. Intact rotator cuff including subscapularis tendon for anatomic shoulder arthroplasty or a repairable subscapularis tendon for reverse shoulder arthroplasty, as determined by preoperative examination or imaging, if indicated or available preoperatively. Imaging is not required for this assessment. 6. Ability and willingness to comply with prescribed post-operative rehabilitation program. 7. Ability and willingness to comply with follow-up visit schedule. 8. Able to understand the informed consent process, including regulatory requirements such as HIPAA authorization, and document informed consent prior to completion of any study-related procedures. 9. Ability to read, understand, and complete subject-reported outcomes in English. Exclusion Criteria: 1. Shoulder arthroplasty requiring a lesser tuberosity osteotomy or revision arthroplasty. 2. Prior index shoulder surgery requiring treatment to the subscapularis. 3. Intraoperative identification of irreparable subscapularis tear (rTSA) 4. Diabetic patients with hemoglobin A1c (HbA1c) level \>8% prior to surgery. 5. Patients with inflammatory arthritis or patients that are immunocompromised, or patients that have a glenoid deficiency. 6. Patients with a known history of hypersensitivity to bovine-derived materials. 7. Hypersensitivity to poly(D,L-lactide) materials. 8. Females of child-bearing potential who are pregnant or plan to become pregnant during the course of the study. 9. Currently involved in any injury litigation or worker's compensation claims relating to the index shoulder. 10. Enrolled, or plans to enroll, in another clinical trial during this study that would affect the outcomes of this study. 11. History of non-compliance with medical treatment, physical therapy/rehabilitation, or clinical study participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Osteoarthritis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Alta Orthopaedics

    Santa Barbara, California, 93101, United States

  • Atlantis Orthopaedics

    Palm Beach Gardens, Florida, 33410, United States

  • Central Indiana Orthopedics

    Carmel, Indiana, 46037, United States

  • HCA Florida - JFK Hospital

    Atlantis, Florida, 33462, United States

  • University of Louisville Physicians, Inc.

    Louisville, Kentucky, 40215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.